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Abstract
Background: The use of systematic literature review to inform evidence based practice in diagnostics is rapidly
expanding. Although the primary diagnostic literature is extensive, studies are often of low methodological quality or
poorly reported. There has been no rigorously evaluated, evidence based tool to assess the methodological quality of
diagnostic studies.
The primary objective of this study was to determine the extent to which variations in the quality of primary studies
impact the results of a diagnostic meta-analysis and whether this differs with diagnostic test type. A secondary objective
was to contribute to the evaluation of QUADAS, an evidence-based tool for the assessment of quality in diagnostic
accuracy studies.
Methods: This study was conducted as part of large systematic review of tests used in the diagnosis and further
investigation of urinary tract infection (UTI) in children. All studies included in this review were assessed using QUADAS,
an evidence-based tool for the assessment of quality in systematic reviews of diagnostic accuracy studies. The impact of
individual components of QUADAS on a summary measure of diagnostic accuracy was investigated using regression
analysis. The review divided the diagnosis and further investigation of UTI into the following three clinical stages: diagnosis
of UTI, localisation of infection, and further investigation of the UTI. Each stage used different types of diagnostic test,
which were considered to involve different quality concerns.
Results: Many of the studies included in our review were poorly reported. The proportion of QUADAS items fulfilled
was similar for studies in different sections of the review. However, as might be expected, the individual items fulfilled
differed between the three clinical stages. Regression analysis found that different items showed a strong association with
test performance for the different tests evaluated. These differences were observed both within and between the three
clinical stages assessed by the review. The results of regression analyses were also affected by whether or not a weighting
(by sample size) was applied. Our analysis was severely limited by the completeness of reporting and the differences
between the index tests evaluated and the reference standards used to confirm diagnoses in the primary studies. Few
tests were evaluated by sufficient studies to allow meaningful use of meta-analytic pooling and investigation of
heterogeneity. This meant that further analysis to investigate heterogeneity could only be undertaken using a subset of
studies, and that the findings are open to various interpretations.
Conclusion: Further work is needed to investigate the influence of methodological quality on the results of diagnostic
meta-analyses. Large data sets of well-reported primary studies are needed to address this question. Without significant
improvements in the completeness of reporting of primary studies, progress in this area will be limited.
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Background
The use of systematic literature review to inform evidence-
based practice in diagnostics is rapidly expanding.
Although the primary diagnostic literature is extensive,
there remain a number of problems for systematic reviews
of diagnostic tests. Appropriate methods for rigorous eval-
uation of diagnostic technologies have been well estab-
lished [1-5]. However, available studies have generally
been poorly designed and reported [6-8]. Similarly,
although a number of quality checklists for diagnostic
accuracy studies have been proposed [9] and there is
growing evidence on the effects of bias in such studies
[10], there has been no rigorously evaluated, evidence-
based quality assessment tool for diagnostic studies.
The objective of this study was to investigate the impact of
quality on the results of a diagnostic meta-analysis, using
regression analysis. A large diagnostic systematic review
was required to enable the use of regression analysis to
investigate the impact of components of quality upon
results.
We have recently completed a systematic review, which
aimed to determine the most appropriate pathway for the
diagnosis and further investigation of UTI in children
[11]. It included an assessment of the accuracy of tests for
three different clinical stages of UTI: the diagnosis UTI,
localisation of infection, and further investigation of
patients with confirmed UTI. The nature of the tests
included in these three clinical sections of this review dif-
fered. Tests used to diagnose UTI were generally labora-
tory-based or near-patient methods, with relatively
objective interpretation of results, e.g. dipstick tests and
microscopy. By contrast, tests used to investigate con-
firmed UTI mainly utilised imaging technologies which
are largely subjective in their interpretation, and where
diagnostic thresholds are difficult to define. Tests used to
localise infection spanned both categories. We hypothe-
sised that the components of methodological quality
affecting results were likely to differ between the three sec-
tions of the review. Such potential differences may indi-
cate a need for topic-specific checklists for the assessment
of quality in diagnostic studies.
A secondary aim of this study was to contribute to the
evaluation of QUADAS, an evidence-based tool for the
assessment of the quality of diagnostic accuracy studies
that was specifically developed for use in systematic
reviews of diagnostic tests [12], by investigating the
importance of specific QUADAS items.
Methods
We used QUADAS [12] (Table 1) to assess the quality of
primary studies included in the review. Items were rated as
'yes', 'no', or 'unclear'. We examined differences in the
individual QUADAS items fulfilled, as well as their impact
on test performance. The review divided the diagnosis and
further investigation of UTI into the following three clini-
cal stages: diagnosis of UTI, localisation of infection, and
further investigation of the UTI. Each stage used different
types of diagnostic test, which were considered to involve
different quality concerns.
Table 1: QUADAS
Item # Description
1. Was the spectrum of patients representative of the patients who will receive the test in practice?
2. Were selection criteria clearly described?
3. Is the reference standard likely to correctly classify the target condition?
4. Is the time period between reference standard and index test short enough to be reasonably sure that the target condition did not 
change between the two tests? (disease progression bias)
5. Did the whole sample or a random selection of the sample, receive verification using a reference standard of diagnosis? (partial 
verification bias)
6. Did patients receive the same reference standard regardless of the index test result? (differential verification bias)
7. Was the reference standard independent of the index test (i.e. the index test did not form part of the reference standard)? 
(incorporation bias)
8. Was the execution of the index test described in sufficient detail to permit replication of the test?
9. Was the execution of the reference standard described in sufficient detail to permit its replication?
10. Were the index test results interpreted without knowledge of the results of the reference standard? (test review bias)
11. Were the reference standard results interpreted without knowledge of the results of the index test? (diagnostic review bias)
12. Were the same clinical data available when test results were interpreted as would be available when the test is used in practice? 
(clinical review bias)
13. Were uninterpretable/ intermediate test results reported?
14. Were withdrawals from the study explained?BMC Medical Research Methodology 2005, 5:20 http://www.biomedcentral.com/1471-2288/5/20
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We analysed results grouped by clinical stage. Within
these groups, we pooled studies of similar tests or test
combinations where sufficient data were available and
where pooling was clinically meaningful. (Table 2) The
minimum number of studies that we required for regres-
sion analysis was ten. This choice was made based on pub-
lished guidance [13,14].
We estimated summary receiver operator characteristic
(SROC) curves using the following equation [15]:
a and b were estimated by regressing D against S for each
study:
D = a + bS
D = {logit (sensitivity) - logit (1-specificity)} = log diag-
nostic odds ratio (DOR)
S = {logit (sensitivity) + logit (1-specificity)}
We used both weighted and unweighted models. For the
weighted model we weighted on sample size. We chose to
weight on sample size rather than inverse variance, a
method sometimes used in this type of analysis, as we
believe that weighting on the inverse variance can produce
biased results. The reason for this bias is that the DOR is
associated with its variance and so large DORs will inevi-
tably have large variances, which will be reflected in the
weightings.
We assessed between study heterogeneity through visual
examination of forest plots and statistically using the Q
statistic [16]. Where sufficient data were available, we
used regression analysis to investigate whether individual
QUADAS items and additional variables thought likely to
be associated with diagnostic accuracy were associated
with the DOR and hence whether differences in these
items between the studies accounted for some of the
observed heterogeneity. Where data were available, the
following additional variables were investigated:
• Patient age (<2 years, <5 years, <12 years and <18 years)
was included to examine possible variation with age
within the paediatric population.
Table 2: Tests included/excluded in the regression analysis
Tests included in the regression analysis (number of studies) Tests for which there were insufficient studies to permit 
regression analysis (number of studies)
Diagnosis
Dipstick: nitrite (23), LE (14), nitrite or LE positive (15) Clinical history (6)
Microscopy: pyuria (28), bacteriuria (22) Dipstick: nitrite and LE positive (9), glucose (4), protein (2), blood (1), 
protein and LE positive (1), combinations of 3 dipstick tests (5)
Microscopy: pyuria or bacteriuria (8), pyuria and bacteriuria (8)
Culture: standard (1), dipslide (1)
Combinations of different tests (10)
Localisation
Ultrasound (20) Clinical history (5)
Laboratory based tests (16)
Imaging techniques: MCUG (7), MRI (1), CT (1), IVP (4), cystography (2), 
scintigraphy (3)
Further investigation
Detection of reflux: Ultrasound (28): standard (11), contrast enhanced 
(17)
Detection of reflux: IVP (4), voiding radionuclide cystography (3), NAG/
creatinine ratio (1), scintigraphy, (3), risk scoring system (1)
Prediction of scarring: ultrasound (2), IVP (1), non-invasive indicators (1), 
MCUG (2)
Detection of scarring: IVP (4), static scintigraphy (7), dynamic scintigraphy 
(2), MCUG (4), cystography (1), MRI (1), US and MCUG (1)
Sensitivity
a
b e Specificity
Specificity
=
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• The geographic region where studies were conducted
was included to account for possible regional differences
in test technology and infective agent.
• Specific variations in index test technique were also
included. For microscopy for pyuria and bacteriuria a var-
iable on whether the sample was centrifuged was
included, and for microscopy for bacteriuria a variable for
Gram stain was included. For ultrasound for the detection
of reflux a variable for whether or not the ultrasound
involved a contrast agent was included.
• The SROC model [15], was extended to include each of
the 14 QUADAS items and each of the variables above as
individual covariates [17]. As each QUADAS item can be
scored as "yes", "no" or "unclear", we included QUADAS
items as categorical variables with 3 possible outcomes,
thus including the comparisons of "yes vs no", and "yes vs
unclear". This allowed us to make some distinction
between associations of aspects of methodological quality
with test performance and associations of completeness of
reporting with test performance. A number of QUADAS
items only received two of the three possible scores (i.e.
were scored either "yes" or "no", or "yes" or "unclear", or
"no" or "unclear"). These items were therefore included as
dichotomous variables.
A multivariate linear regression analysis was conducted.
Initially, we performed univariate analysis with all items
included separately in the model. Items that showed mod-
erate evidence of an association with D, defined as p <
0.10, were investigated further using step-down regression
analysis. All items found to show moderate evidence of an
association in the univariate models were entered into the
multivariate model, then dropped in a step-wise fashion
with the item with the weakest evidence of an association
(largest p-value) dropped first. For covariates with more
than one level, evidence of an association of one indicator
variable with test performance was considered sufficient
for inclusion in the model. The final model was achieved
when all items remaining showed strong evidence of an
association with D, defined as p < 0.05. Interaction terms
were not included. Associations of covariates with D were
expressed as relative diagnostic odds ratios (RDOR). The
DOR is used as an overall measure of diagnostic accuracy.
It is calculated as the odds of positivity among diseased
persons, divided by the odds of positivity among non-dis-
eased. When a test provides no diagnostic evidence then
the DOR is 1.0. The RDOR is calculated as the DOR when
the covariate is present divided by the DOR when the cov-
ariate is absent. It therefore provides an indicator of the
overall impact on diagnostic accuracy of the presence of a
given covariate.
Numbers of quality items fulfilled by studies in the three sections of the review Figure 1
Numbers of quality items fulfilled by studies in the three sections of the review.
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Results
Results of QUADAS assessment
The proportion of QUADAS items fulfilled by studies
included in our systematic review was similar for each of
the three clinical stages assessed in the review. Studies
evaluating tests to diagnose UTI fulfilled a median of 8
(range 5–13) items, those evaluating tests used to localise
infection also fulfilled a median of 8 (range 3–13) items,
and those evaluating further investigations fulfilled a
median of 7.5 (range 3–12) items. Figure 1 illustrates the
number of QUADAS items fulfilled by studies in each cat-
egory. The similarity in numbers of QUADAS items
fulfilled masks apparent differences in the individual
items fulfilled.
Figure 2 shows the proportion of studies that scored "yes",
"no" and "unclear" for each of the QUADAS items, sepa-
rately for the three sections of the review.
Tests for the diagnosis of UTI (n = 79 studies) [18-96]
The use of an inappropriate spectrum of patients and
inadequate reporting of inclusion criteria were problem-
atic for studies in this category. The majority of studies
provided insufficient details on how the reference stand-
ard was performed. Studies failed to report sufficient
details on clinical review bias, diagnostic review bias and
test review bias to judge whether these were avoided.
Study withdrawals and handling of uninterpretable
results were also poorly reported.
Tests for the localisation of infection (n = 39 studies) [48,69,97-
133]
The time delay between the index test and reference stand-
ard was more of a problem with these studies than with
those on the diagnosis of UTI. The use of an appropriate
reference standard was also an issue in some of these stud-
ies. Spectrum composition and reporting of details of how
children were selected for inclusion in the study was better
in these studies than in the studies of the diagnosis of UTI.
Only around half of studies provided sufficient details of
how the index test and reference standard were performed
to allow replication of these tests. More studies in this cat-
egory, almost 40%, provided information indicating that
test and diagnostic review bias had been avoided, in the
remainder of studies this information was not reported.
As with studies of the diagnosis of UTI, reporting of clini-
cal review bias, handling of uninterpretable results, and
withdrawals from the study was poor.
Proportion of studies rated as yes, no or unclear for each of the QUADAS items, separately for diagnosis of UTI, localisation  of infection and investigation of confirmed UTI Figure 2
Proportion of studies rated as yes, no or unclear for each of the QUADAS items, separately for diagnosis of UTI, localisation 
of infection and investigation of confirmed UTI.BMC Medical Research Methodology 2005, 5:20 http://www.biomedcentral.com/1471-2288/5/20
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Tests for the further investigation of confirmed UTI (n = 71 studies) 
[134-204]
As with studies of the diagnosis of UTI, spectrum compo-
sition and reporting of inclusion criteria were poor in this
group. The time delay between the index test and refer-
ence standard was also an issue in many of these studies.
Around half of studies reported that diagnostic and test
review bias had been avoided, the remaining studies did
not report whether the index test and reference standard
were interpreted blind to the results of each other. This
was similar to the situation seen for studies on the locali-
sation of infection. Reporting of the reference standard
was poor. As in all previous groups, studies also provided
very little information on whether appropriate clinical
information was available when test results were
interpreted, how uninterpretable results were handled,
and whether there were any withdrawals from the study
and if so whether all withdrawals were accounted for.
Results of multivariate regression analysis
Tests for the diagnosis of UTI
Tests involving dipstick or microscopy techniques were
the only categories where enough studies were available
to enable regression analysis. Table 3 summarises the
results of the regression analysis for studies assessing dip-
stick tests. For dipstick to detect urinary nitrite (23 stud-
ies) [20,26,28,34,36,40,41,43,52,54-
57,60,63,66,72,74,84,88,93-95], the weighted analysis
found that studies reporting that clinical review bias had
been avoided had a DOR 4.7 (95% CI: 1.7, 12.7) times
greater than those which did not report on whether clini-
cal information was available to those interpreting the test
results (p = 0.004). This is what would be expected, as the
DOR is likely to be higher when those interpreting test
results have access to appropriate clinical information
similar to that, which would be available in practice. No
studies reported the presence of clinical review bias. This
was the only item investigated to show strong evidence of
an association with test performance in the weighted mul-
tivariate analysis, although age and geographic region did
show moderate evidence of an association in the univari-
ate analysis. The unweighted analysis showed slightly dif-
ferent results. The same three items were found to show at
least moderate evidence of an association in the univariate
analysis. However, only country remained in the multi-
variate model, suggesting that studies conducted in North
America showed higher accuracy than studies conducted
in Europe or other areas (p < 0.05).
For dipsticks measuring urinary leukocyte esterase (14
studies) [20,28,34,36,43,56,57,60,63,66,72,84,94,95]
and for dipsticks for the presence of either nitrite or leuko-
cyte esterase (15 studies) [19-21,28,34,56,60,63,66,84-
86,92,94-96], no items showed strong evidence of an
association with the DOR in the weighted analysis. How-
ever, for urinary leukocyte esterase, the unweighted anal-
ysis found strong evidence of an association between
patient age and the DOR. There was strong evidence (p =
0.015) that the dipstick was more accurate in children
aged <12 years than in those aged <2 years (RDOR = 28.1,
95% CI: 2.3, 343.3). There was no evidence of any differ-
ence in accuracy between children aged <18 years and
those aged <2 years (p = 0.703), and very little evidence of
any difference between children aged <5 years and those
aged <2 years (p = 0.158).
Table 4 summarises the results of the regression analysis
for studies that assessed the accuracy of microscopy. In
studies evaluating microscopy to detect pyuria three items
showed a strong association with test performance in the
weighted analysis (28 studies) [19-
23,28,29,34,35,41,43,46,47,49,50,58,59,63,67,70,75,77,
80,81,83,85,92-94]. The DOR was 1.3 (95% CI: 1.1, 1.6;
p = 0.007) times higher in studies that adequately
reported details of the reference standard execution. The
DOR was lower, RDOR = 0.2 (95% CI: 0.1, 0.4; p < 0.001)
in studies that did not report on reasons for withdrawals
compared to studies in which it was unclear whether there
were any withdrawals, and 1.8 times higher (95 % CI: 1.0,
3.4; p = 0.056) in studies in which withdrawals were
accounted for compared to those in which this was
unclear. The DOR was lower, RDOR = 0.2 (95% CI: 0.1,
0.3; p < 0.001), in studies where samples were centrifuged
compared to studies in which samples were not centri-
fuged. In the unweighted analysis, only centrifugation
showed any evidence of an association with test perform-
ance (p = 0.08). All of these items, with the exception of
centrifugation, relate to the completeness of reporting.
The association for centrifugation is counter-intuitive, as
we would expect centrifugation of the sample to lead to
improved test accuracy.
Two items showed a strong evidence of an association
with the DOR in the weighted analysis of studies evaluat-
ing microscopy to detect bacteriuria (22 studies)
[20,21,23,28,34,35,41,47,50,61-
64,67,70,76,77,80,85,90,91,94]. The DOR was 3.0 (95%
CI: 1.6, 5.5, p = 001) times greater in studies in which
incorporation bias was present compared to those in
which it was avoided, and 5.3 (95% CI: 2.3, 12.0, p =
0.001) times greater if samples were Gram stained. We
would expect both Gram staining and the presence of
incorporation bias to increase test performance as found
in the analysis. The unweighted analysis found very simi-
lar results.
Tests for the localisation of infection
Only the evaluation of ultrasound for the localisation of
infection provided sufficient data to enable the conduct of
regression analysis (20 studies) [48,69,97,99-102,109-BMC Medical Research Methodology 2005, 5:20 http://www.biomedcentral.com/1471-2288/5/20
Page 7 of 16
(page number not for citation purposes)
111,113-115,117,118,121,126,128,132,133]. None of
the QUADAS items, or other items investigated, showed
moderate evidence of an association with the DOR in this
analysis, using either the weighted or unweighted model.
Tests for the further investigation of confirmed UTI
Table 5 summarises the results of the regression analysis
for studies assessing this clinical stage. The use of ultra-
sound to detect reflux was the only test in this category
with sufficient data to support regression analysis (28
studies)
[69,135,137,140,141,150,152,153,155,164,169,170,172
,176-178,181,185,187,189,190,195-198,202-204]. Three
items showed strong evidence of an association with the
DOR in the weighted analysis. The DOR was 8.0 (95% CI:
2.9, 22.0; p < 0.001) times greater in studies that used con-
trast enhanced ultrasound compared to those that used
standard ultrasound. As this was also thought to be a clin-
ically important variable it was included in all further
analyses. The DOR was 1.4 (95% CI: 1.0, 1.9; p = 0.033)
Table 3: Results of the regression analysis for dipstick tests for the diagnosis of UTI
Univariate analysis Multivariate model
Variable* RDOR (95% CI) p-value RDOR (95% CI) p-value
Nitrite dipstick – weighted (n = 23 studies)
Clinical review bias avoided: yes vs unclear 4.7 (1.7, 12.7) 0.004 4.7 (1.7, 12.7) 0.004
Age <5 years vs <2 years 5.8 (0.3, 101.8) 0.213 Dropped$
Age <12 years vs <2 years 2.2 (0.1, 35.8) 0.548 Dropped
Age <18 years vs <2 years 3.6 (0.9, 14.9) 0.076 Dropped
Europe vs North America 0.3 (0.1,0.9) 0.041 Dropped
Other areas vs North America 0.3 (0.1, 1.0) 0.050 Dropped
Nitrite dipstick – unweighted (n = 23 studies)
Clinical review bias avoided: yes vs unclear 3.4 (0.9, 13.7) 0.078 Dropped
Age <5 years vs <2 years 7.3 (0.9, 61.8) 0.067 Dropped
Age <12 years vs <2 years 2.9 (0.5, 18.3) 0.243 Dropped
Age <18 years vs <2 years 3.8 (1.1, 13.4) 0.039 Dropped
Europe vs North America 0.3 (0.1, 1.0) 0.044 0.3 (0.1, 1.0) 0.044
Other areas vs North America 0.3 (0.1, 1.2) 0.089 0.3 (0.1, 1.2) 0.089
LE dipstick – weighted (n = 14 studies)
No association at p < 0.10
LE dipstick – unweighted (n = 14 studies)
Test details reported: yes vs no 19.0 (1.9, 192.2) 0.017 Dropped
Age <5 years vs <2 years 5.4 (0.5, 64.2) 0.158 5.4 (0.5, 64.2) 0.158
Age <12 years vs <2 years 28.1 (2.3, 343.3) 0.015 28.1 (2.3, 343.3) 0.015
Age <18 years vs <2 years 1.3 (0.3, 4.7) 0.703 1.3 (0.3, 4.7) 0.703
Nitrite or leukocyte esterase dipstick – weighted (n = 15 studies)
Reference standard details reported 4.5 (0.9, 22.5) 0.064 Dropped
North America vs Europe 5.0 (0.8, 10.5) 0.076 Dropped
North America vs Other areas 1.1 (0.28, 5.0) 0.854 Dropped
Nitrite or leukocyte esterase dipstick – unweighted (n = 15 studies)
No association at p < 0.10
*Only items that showed moderate evidence (p < 0.10) for an association with the DOR in the univariate analysis are included.
$Items were dropped where there were too few studies in one category to allow a coefficient to be calculated.BMC Medical Research Methodology 2005, 5:20 http://www.biomedcentral.com/1471-2288/5/20
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times higher in studies that reported that disease progres-
sion bias had been avoided compared to those in which
this information was not reported. No studies reported
sufficient information to determine that disease progres-
sion bias was present. Studies in which details were pro-
vided on reasons for withdrawals had DORs that were 2.8
times higher (95% CI: 1.1, 6.9, p = 0.033) than those in
which it was unclear whether there had been any with-
drawals. There was no evidence of any difference in the
DOR between studies that did not report on reasons for
withdrawals and studies in which it was unclear whether
there were any withdrawals (p = 0.502). In the
unweighted analysis, only two items showed a strong evi-
dence of an association with the DOR. As in the weighted
Table 4: Results of the regression analysis for microscopy for the diagnosis of UTI
Univariate analysis Multivariate model
Variable* RDOR (95% CI) p-value RDOR (95% CI) p-value
Microscopy for pyuria: weighted (n = 28 studies)
Selection criteria reported: yes vs no 2.4 (1.0, 5.9) 0.057 Dropped$
Reference standard details reported: yes vs no 3.6 (0.8, 16.1) 0.089 1.3 (1.1, 1.6) 0.007
Test review bias avoided: yes vs unclear 4.8 (1.6, 14.7) 0.008 Dropped
Diagnostic review bias avoided: yes vs unclear 5.5 (1.8, 17.1) 0.005 Dropped
Uninterpretable results reported: no vs unclear 0.3 (0.0, 4.1) 0.364 Dropped
Uninterpretable results reported: yes vs unclear 2.9 (0.9, 9.1) 0.073 Dropped
Withdrawals accounted for: no vs unclear 0.2 (0.1, 0.7) 0.012 0.2 (0.1, 0.4) <0.001
Withdrawals accounted for: yes vs unclear 1.9 (0.7, 5.3) 0.200 1.8 (1.0, 3.4) 0.056
Europe vs North America 0.3 (0.1, 1.6) 0.190 Dropped
Asia vs North America 0.6 (0.1, 6.6) 0.646 Dropped
Other areas vs North America 0.2 (0.0, 1.3) 0.090 Dropped
Age <5 years vs <2 years 0.1 (0.0, 0.4) 0.004 Dropped
Age <12 years vs <2 years 0.1 (0.0, 0.3) 0.004 Dropped
Age <18 years vs <2 years 0.2 (0.1, 0.5) 0.001 Dropped
Sample centrifuged: yes vs no 0.3 (0.1, 0.6) 0.005 0.2 (0.1, 0.3) <0.001
Microscopy for pyuria: unweighted (n = 28 studies)
Age <5 years vs <2 years 0.3 (0.1, 1.1) 0.076 Dropped
Age <12 years vs <2 years 0.5 (0.1, 2.1) 0.337 Dropped
Age <18 years vs <2 years 0.3 (0.1, 1.0) 0.048 Dropped
Sample centrifuged 0.5 (0.2, 1.1) 0.080 0.5 (0.2, 1.1) 0.080
Microscopy for bacteriuria: weighted (n = 22 studies)
Incorporation bias avoided: no vs yes 24.5 (1.0, 604.4) 0.050 3.0 (1.6, 5.5) 0.001
Diagnostic review bias avoided: yes vs unclear 3.2 (0.8, 12.8) 0.092 Dropped
Gram stain used: yes vs no 3.6 (1.3, 10.4) 0.018 5.3 (2.3, 12.0) 0.001
Microscopy for bacteriuria: unweighted (n = 22 studies)
Disease progression bias: yes vs unclear 0.05 (0.0, 1.5) 0.083 Dropped
Incorporation bias avoided: no vs yes 32.5 (1.2, 895.0) 0.041 3.2 (1.6, 6.4) 0.003
Uninterpretable results reported: yes vs unclear 7.1 (1.1, 46.9) 0.042 Dropped
Withdrawals reported: no vs unclear 6.6 (1.0, 43.3) 0.049 Dropped
Withdrawals reported: yes vs unclear 2.2 (0.3, 18.7) 0.447 Dropped
Sample centrifuged: yes vs no 0.2 (0.0, 1.1) 0.058 Dropped
Gram stain used: yes vs no 3.9 (0.9, 16.3) 0.062 6.5 (2.0, 21.2) 0.004
*Only items that showed moderate evidence (p < 0.10) for an association with the DOR in the univariate analysis are included.
$Items were dropped where there were too few studies in one category to allow a coefficient to be calculated.BMC Medical Research Methodology 2005, 5:20 http://www.biomedcentral.com/1471-2288/5/20
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analysis there was very strong evidence that the DOR was
higher in studies that used contrast enhanced ultrasound
than those that used standard ultrasound (RDOR = 29.8,
95% CI: 13.5, 65.8, p < 0.001). Studies in which partial
verification bias was avoided had DORs 4.1 times higher
(95% CI: 1.1, 14.8) than those that did not (p = 0.034).
Discussion
The methodological quality of primary studies remains a
significant issue for systematic reviews of diagnostic tests
[8,205,206]. The STARD initiative has provided clear
guidance for the reporting of diagnostic accuracy studies
[5]. This should have a positive impact on the quality of
the diagnostic literature in the future. The QUADAS tool
facilitates systematic evaluation of the quality of diagnos-
tic accuracy studies, and was specifically developed for use
in systematic reviews of diagnostic tests [12]. However,
where studies are poorly reported the information that
can be derived from quality assessment becomes limited.
We cannot know whether an unreported QUADAS item
reflects a true methodological flaw or poor reporting of a
study that may be methodologically sound. Many of the
studies included in our review were poorly reported. Our
assessment of the impact of components of methodolog-
ical quality on diagnostic accuracy may therefore partially
reflect completeness of reporting. Whilst poor reporting
remains a widespread problem, it is almost impossible to
assess the impact of components of methodological qual-
ity on the results of diagnostic meta-analyses.
The common practice of using summary quality scores in
systematic reviews has been widely debated elsewhere
[207-209]. Summary scores, when used to inform quality-
based analyses, may mask important effects of individual
quality components [210]. As we report, the numbers of
QUADAS items that were adequately addressed by studies
included in our review were similar between the three
clinical stages assessed in the review. Had the number of
QUADAS items fulfilled been used as a summary score,
potentially important variations in the individual items
fulfilled would have been hidden. We therefore advocate
that components of quality assessment should be
reported fully, and their impact on outcome measures
analysed individually rather than as summary scores.
Although ours was a large review, it included 187 studies
reporting 487 data sets, our analysis of the impact of
methodological quality on diagnostic accuracy was
severely limited both by the diversity of the included stud-
ies (few tests were evaluated by sufficient studies to allow
meaningful use of meta-analytic pooling and investiga-
tion of heterogeneity), and by incomplete reporting. All of
Table 5: Results of the regression analysis for ultrasound for the diagnosis of reflux
Univariate analysis Multivariate analyis
Variable* RDOR (95% CI) p-value RDOR (95% CI) p-value
Ultrasound for the detection of reflux: weighted (n = 28 studies)
Use of contrast enhanced ultrasound: yes vs no 23.9 (9.8, 58.8) <0.001 8.0 (2.9, 22.0) <0.001
Ultrasound for the detection of reflux, with ultrasound type forced into the model: weighted (n = 28 studies)
Appropriate reference standard: yes vs unclear + 0.2 (0.0, 1.0) 0.047 Dropped$
Disease progression bias avoided: yes vs unclear 3.5 (1.4, 9.2) 0.011 1.4 (1.0, 1.9) 0.033
Withdrawals accounted for: yes vs unclear 3.2 (1.2, 8.5) 0.020 2.8 (1.1, 6.9) 0.027
Withdrawals accounted for: no vs unclear (0.4, 0.1, 1.7) 0.175 0.6 (0.1, 2.8) 0.502
Ultrasound for the detection of reflux: unweighted (n = 28 studies)
Use of contrast enhanced ultrasound: yes vs no 29.8 (13.5, 65.8) <0.001 29.8 (13.5, 65.8) <0.001
Ultrasound for the detection of reflux, with ultrasound type forced into the model: unweighted (n = 28 studies)
Appropriate reference standard *: yes vs unclear 0.2 (0.0, 1.2) 0.075 Dropped
Partial verification bias avoided: yes vs no 4.1 (1.1, 14.8) 0.034 4.1 (1.1, 14.8) 0.034
*Only items that showed moderate evidence (p < 0.10) for an association with the DOR in the univariate analysis are included.
+Only 1 unclear
$Items were dropped where there were too few studies in one category to allow a coefficient to be calculated.BMC Medical Research Methodology 2005, 5:20 http://www.biomedcentral.com/1471-2288/5/20
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the data sets used were sub-optimal, in that the numbers
of observations were low in comparison to the number of
variables investigated in the multivariate analyses[13].
Although different types of diagnostic tests were evaluated
in the three clinical stages used by the review, generalisi-
bility is limited in that all data concerned a single
condition (UTI). A number of the items found to be asso-
ciated with test performance related to specific test meth-
odologies (e.g. Gram stain and contrast-enhanced
ultrasound) and have no generalisability elsewhere. These
items were found to show association in both the
weighted and unweighted analyses. For the individual
quality items there were some differences between the
results of the weighted and unweighted analyses. In gen-
eral, the results of weighted analyses showed more intui-
tive associations. Unweighted analyses more often
produced results that were difficult to explain, for exam-
ple, in leukocyte esterase dipstick tests the unweighted
analysis found that the test was more accurate in the
group of children aged <12 years than in those aged <2
years. This might be expected and would probably reflect
a higher likelihood of sample contamination in younger
children, however, no difference in accuracy was found
between under 18's and children aged <2 years. For both
tests on the diagnosis of and further investigation of UTI
weighted analyses showed an association between a
number of variables relating to quality of reporting and
diagnostic accuracy (well reported studies had higher
DORs). We might expect this association to extend to
diagnostic accuracy studies of all types of tests, but the
present study is not adequate to demonstrate this.
Weighted analysis of studies of ultrasound for the detec-
tion of reflux showed that the DOR was higher where
studies reported information to determine that disease
progression bias had been avoided. Disease progression
bias is a particular issue for imaging studies of this type
where follow-up examinations (used as the reference
standard of diagnosis) may be scheduled some time after
ultrasound (usually the initial examination). This associ-
ation was not shown in the unweighted analysis.
The information derived from these analyses is also lim-
ited by the use of the summary ROC approach to pool
studies. This method takes the DOR as the dependent var-
iable. The DOR is used as a single indicator of test per-
formance and shows how much more frequently a
positive test result occurs in a person with the condition
of interest than in one without the condition, relative to
how much more frequently a negative result occurs in a
person without the condition than in one with the condi-
tion. Using the DOR to investigate heterogeneity means
that we cannot assess whether the factors investigated are
associated with paired measures of diagnostic accuracy,
such as sensitivity and specificity, or positive and negative
likelihood ratios. Often factors that lead to an increase in
sensitivity will lead to a decrease in specificity and vice
versa. Factors that lead to this pattern of change may have
no effect on an overall measure such as the DOR. Using
the DOR to investigate heterogeneity may thus miss rele-
vant clinical associations. Recently a new method for
pooling sensitivity and specificity has been developed.
This method is known as the "bivariate model" [211]. It
preserves the underlying two-dimensional nature of the
data and produces direct pooled estimates of sensitivity
and specificity, incorporating any correlation that might
exist between these two measures. The model can be
extended to include explanatory variables leading to sep-
arate effects on sensitivity and specificity. This method has
two advantages over the standard methods: (1) the
pooled estimates of sensitivity and specificity take into
account the correlation between these two measures; (2)
the effect of possible sources of heterogeneity on both
sensitivity and specificity can be investigated in a single
model rather than just looking at the effect of these varia-
bles on a single measure of test performance, the DOR.
These methods may have potential applications in future
studies of this type.
Conclusion
Given the limitations we describe, the results of this study
should be treated as hypothesis generating. Further work
is needed to elucidate the influence of components of the
methodological quality of primary studies on the results
of diagnostic meta-analyses. Large data sets of well-
reported primary studies are needed to address this
question. Without significant improvements in the
reporting of primary studies, progress in this area will be
limited. The components of quality assessment should
always be reported, and their impact on summary out-
come measures be investigated, individually rather than
as summary quality scores. Careful consideration should
be given to the choice of weighting when conducting
regression analyses. Weighting by sample size appears the
most appropriate method for analyses of diagnostic accu-
racy studies, but this area requires further investigation.
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